Torsade de pointes probably induced by sparfloxacin.
Sparfloxacin is a new fluoroquinolone with potent antitubercular activity. We report a case of a 37 year old female who was on this drug as part of modified antitubercular therapy and developed torsade de pointes on this drug.
Kakar
A
A
Department of Internal Medicine, Sir Ganga Ram Hospital New Delhi.
Byotra
S P
SP
D000328:Adult; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D024841:Fluoroquinolones; D006801:Humans; D016171:Torsades de Pointes / Q000139:chemically induced*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D000890:Anti-Infective Agents; D000995:Antitubercular Agents; D024841:Fluoroquinolones; C061363:sparfloxacin